Abstract:Background: MicroRNAs (miRNAs) play a key role in the development of lung cancer; however, there has been little research on the role of miR-556-3p. The present study focused on the function and mechanism of miR-556-3p in lung squamous cell carcinoma (SqCLC). Methods: The Cancer Genome Atlas (TCGA) database was searched to analyze the expression of miR-556-3p in SqCLC, and its relationship with prognosis and survival. Quantitative real-time reverse transcription PCR was used to detect the expression difference of miR-556-3p in normal lung epithelial cells (BEAS-2B) and SqCLC cells (H226 and SK-MES-1). The proliferation, migration, and invasion of H226 and SK-MES-1 cells were detected by Cell Counting Kit-8 (CCK-8), wound healing, and Transwell assays, respectively, after transfection with miR-556-3p-mimics. The changes in the levels of key proteins in the epithelial-mesenchyme transition (EMT) signaling pathway were detected using western blotting. Bioinformatic analyses predicted the target gene of miR-556-3p, which was verified using luciferase reporter gene assays. The role of miR-556-3p in SqCLC was verified in a nude mouse tumorigenesis model. Results: Analysis of 523 patients with SqCLC in the TCGA database showed that the overall survival (OS) of patients with high miR-556-3p expression was significantly better than that of patients with low miR-556-3p expression (P < 0.05). Compared with that in BEAS-2B cells, miR-556-3p expression was downregulated in H226 and SK-MES-1. After transfection with a miR-556-3p-mimic, CCK-8 analysis showed that the proliferation rate of H226 and SK-MES-1 cells decreased by 66.6% and 60.1% compared with that of the control group. Wound healing assays showed that the migration ability of H226 and SK-MES-1 overexpressing miR-556-3p cells decreased significantly compared with the control group (P < 0.05). Transwell assays showed that the invasion ability of H226 and SK-MES-1 cells overexpressing miR-556-3p was also significantly reduced compared with that the control group (P < 0.05). Western blotting showed that E-Cadherin levels were significantly upregulated after transfection of H226 and SK-MES-1 cells with the miR-556-3p-mimic, while N-cadherin and Vimentin levels were significantly downregulated. Luciferase reporter assays showed that miR-556-3p could bind to the promoter region ofNUAK1(encoding NUAK family kinase 1), and the exogenous expression ofNUAK1could reverse the migration and invasion inhibition by miR-556-3p on H226 and SK-MES-1 cells.In vivoexperiments showed that miR-556-3p also inhibited tumor growth. Conclusions: MiR-556-3p inhibits EMT by targetingNUAK1, thus inhibiting the migration and invasion of SqCLC. Thus, miR-556-3p might be developed as a target to treat SqCLC.

Mir-140-3p Functions As a Tumor Suppressor in Squamous Cell Lung Cancer by Regulating BRD9.

MiR-223-3p Functions As a Tumor Suppressor in Lung Squamous Cell Carcinoma by Mir-223-3p-mutant P53 Regulatory Feedback Loop.

miR‐140‐3p inhibits colorectal cancer progression and its liver metastasis by targeting BCL9 and BCL2

Mir-199A-3p/5p Regulate Tumorgenesis Via Targeting Rheb in Non-Small Cell Lung Cancer

Circ_CSPP1 Regulates the Development of Non-small Cell Lung Cancer Via the Mir-486-3p/brd9 Axis

MiR-141-3p Functions As a Tumor Suppressor Through Directly Targeting ZFR in Non-Small Cell Lung Cancer.

Mir-124-3p Functions As a Tumor Suppressor in Breast Cancer by Targeting CBL

Mir-342-3p Targets Rap2b to Suppress Proliferation and Invasion of Non-Small Cell Lung Cancer Cells

MiR-143-3p Suppresses the Progression of Nasal Squamous Cell Carcinoma by Targeting Bcl-2 and IGF1R.

Mir-592 Functions As a Tumor Suppressor in Human Non-Small Cell Lung Cancer by Targeting SOX9.

MiR‐34b‐3p Represses Cell Proliferation, Cell Cycle Progression and Cell Apoptosis in Non‐small‐cell Lung Cancer (NSCLC) by Targeting CDK4

Overexpression of mir-489-3p inhibits proliferation and migration of non-small cell lung cancer cells by suppressing the HER2/PI3K/AKT/Snail signaling pathway

MicroRNA-3613-3p Functions As a Tumor Suppressor and Represents a Novel Therapeutic Target in Breast Cancer.

Down-Regulation of Mir-4500 Promoted Non-Small Cell Lung Cancer Growth

Mir-556-3p Inhibits SqCLC via NUAK1

Data from Downregulation of DNMT3A by Mir-708-5p Inhibits Lung Cancer Stem Cell–like Phenotypes Through Repressing Wnt/β-catenin Signaling

miR-3607-3p suppresses non-small cell lung cancer (NSCLC) by targeting TGFBR1 and CCNE2

Mir-215 Functions As a Tumor Suppressor and Directly Targets ZEB2 in Human Non-Small Cell Lung Cancer

Mir-137 Silencing Of Brd4 Suppresses Oral Squamous Cell Carcinoma Cells Proliferation, Migration And Invasion

MiR-193a-3p is an Important Tumour Suppressor in Lung Cancer and Directly Targets KRAS

MiR-106b-5p Promotes Proliferation and Inhibits Apoptosis by Regulating BTG3 in Non-Small Cell Lung Cancer.